EU regulator backs extending RoActemra use for adults with severe COVID-19
The European Union's drug regulator on Monday recommended extending the use of Roche's RoActemra for adults with COVID-19 on systemic treatment with corticosteroids and those who need oxygen support or mechanical ventilation.
By : migrator
Update: 2021-12-06 15:12 GMT
Geneva
The European Medicines Agency (EMA) said its human medicines committee evaluated data from a main study involving over 4,000 hospitalised adults, and concluded the medicine's benefits outweigh the risks for these patients.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android